 | • レポートコード：20QY06-00181 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、147ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、CRISPRおよびCRISPR関連（Cas）遺伝子のグローバル市場について種類別（ゲノム編集、遺伝子工学、gRNAデータベース/遺伝子ライブラリー、CRISPRプラスミド、ヒト幹細胞、遺伝子組換え生物/作物、細胞株工学）、用途別（バイオテクノロジー企業、製薬会社、学術機関、研究開発機関）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・CRISPRおよびCRISPR関連（Cas）遺伝子市場の概要 ・世界の主要地域別CRISPRおよびCRISPR関連（Cas）遺伝子市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のCRISPRおよびCRISPR関連（Cas）遺伝子市場規模2015-2026：種類別（ゲノム編集、遺伝子工学、gRNAデータベース/遺伝子ライブラリー、CRISPRプラスミド、ヒト幹細胞、遺伝子組換え生物/作物、細胞株工学） ・世界のCRISPRおよびCRISPR関連（Cas）遺伝子市場規模2015-2026：用途別（バイオテクノロジー企業、製薬会社、学術機関、研究開発機関） ・CRISPRおよびCRISPR関連（Cas）遺伝子の北米市場規模2015-2020 ・CRISPRおよびCRISPR関連（Cas）遺伝子のヨーロッパ市場規模2015-2020 ・CRISPRおよびCRISPR関連（Cas）遺伝子の中国市場規模2015-2020 ・CRISPRおよびCRISPR関連（Cas）遺伝子の日本市場規模2015-2020 ・CRISPRおよびCRISPR関連（Cas）遺伝子の東南アジア市場規模2015-2020 ・CRISPRおよびCRISPR関連（Cas）遺伝子のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Caribou Biosciences、Addgene、CRISPR THERAPEUTICS、Merck KGaA、Mirus Bio LLC、Editas Medicine、Takara Bio USA、Thermo Fisher Scientific、Horizon Discovery Group、Intellia Therapeutics、GE Healthcare Dharmacon） ・CRISPRおよびCRISPR関連（Cas）遺伝子の製造コスト分析 ・販売チャネル、流通業者、顧客 ・CRISPRおよびCRISPR関連（Cas）遺伝子の市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global CRISPR And CRISPR-Associated (Cas) Genes Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global CRISPR And CRISPR-Associated (Cas) Genes market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Clustered regularly interspaced short palindromic repeats (CRISPR) are segments of prokaryotic DNA containing short repetitions of base sequences. Each repetition is followed by short segments of “spacer DNA” from previous exposures to a bacteriophage virus or plasmid.
The CRISPR/Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages, and provides a form of acquired immunity. CRISPR associated proteins (Cas) use the CRISPR spacers to recognize and cut these exogenous genetic elements in a manner analogous to RNA interference in eukaryotic organisms. CRISPRs are found in approximately 40% of sequenced bacterial genomes and 90% of sequenced archaea.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the CRISPR And CRISPR-Associated (Cas) Genes market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the CRISPR And CRISPR-Associated (Cas) Genes industry.
Based on our recent survey, we have several different scenarios about the CRISPR And CRISPR-Associated (Cas) Genes YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 713.8 million in 2019. The market size of CRISPR And CRISPR-Associated (Cas) Genes will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global CRISPR And CRISPR-Associated (Cas) Genes market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global CRISPR And CRISPR-Associated (Cas) Genes market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global CRISPR And CRISPR-Associated (Cas) Genes market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global CRISPR And CRISPR-Associated (Cas) Genes market. The report also includes nautical information, where it shows CRISPR And CRISPR-Associated (Cas) Genes market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global CRISPR And CRISPR-Associated (Cas) Genes market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global CRISPR And CRISPR-Associated (Cas) Genes market.
CRISPR And CRISPR-Associated (Cas) Genes industry is relatively concentrated, manufacturers are mostly in the Europe and North America. Among them, North America region accounted for more than 45.70% of the total market of global CRISPR And CRISPR-Associated (Cas) Genes.
Geographical Analysis:
Based on region, the global CRISPR And CRISPR-Associated (Cas) Genes market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global CRISPR And CRISPR-Associated (Cas) Genes market are
Caribou Biosciences
Addgene
CRISPR THERAPEUTICS
Merck KGaA
Mirus Bio LLC
Editas Medicine
Takara Bio USA
Thermo Fisher Scientific
Horizon Discovery Group
Intellia Therapeutics
GE Healthcare Dharmacon
Segment by Type
Genome Editing
Genetic engineering
gRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering
Segment by Application
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global CRISPR And CRISPR-Associated (Cas) Genes market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global CRISPR And CRISPR-Associated (Cas) Genes market.
• The market share of the global CRISPR And CRISPR-Associated (Cas) Genes market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global CRISPR And CRISPR-Associated (Cas) Genes market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global CRISPR And CRISPR-Associated (Cas) Genes market.
1 CRISPR And CRISPR-Associated (Cas) Genes Market Overview
1.1 CRISPR And CRISPR-Associated (Cas) Genes Product Scope
1.2 CRISPR And CRISPR-Associated (Cas) Genes Segment by Type
1.2.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales by Type (2020-2026)
1.2.2 Genome Editing
1.2.3 Genetic engineering
1.2.4 gRNA Database/Gene Librar
1.2.5 CRISPR Plasmid
1.2.6 Human Stem Cells
1.2.7 Genetically Modified Organisms/Crops
1.2.8 Cell Line Engineering
1.3 CRISPR And CRISPR-Associated (Cas) Genes Segment by Application
1.3.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales Comparison by Application (2020-2026)
1.3.2 Biotechnology Companies
1.3.3 Pharmaceutical Companies
1.3.4 Academic Institutes
1.3.5 Research and Development Institutes
1.4 CRISPR And CRISPR-Associated (Cas) Genes Market Estimates and Forecasts (2015-2026)
1.4.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales Growth Rate (2015-2026)
1.4.2 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue and Growth Rate (2015-2026)
1.4.3 Global CRISPR And CRISPR-Associated (Cas) Genes Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): CRISPR And CRISPR-Associated (Cas) Genes Industry Impact
1.5.1 How the Covid-19 is Affecting the CRISPR And CRISPR-Associated (Cas) Genes Industry
1.5.1.1 CRISPR And CRISPR-Associated (Cas) Genes Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and CRISPR And CRISPR-Associated (Cas) Genes Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for CRISPR And CRISPR-Associated (Cas) Genes Players to Combat Covid-19 Impact
2 CRISPR And CRISPR-Associated (Cas) Genes Estimate and Forecast by Region
2.1 Global CRISPR And CRISPR-Associated (Cas) Genes Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global CRISPR And CRISPR-Associated (Cas) Genes Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Region (2015-2020)
2.2.2 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue Market Share by Region (2015-2020)
2.3 Global CRISPR And CRISPR-Associated (Cas) Genes Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States CRISPR And CRISPR-Associated (Cas) Genes Estimates and Projections (2015-2026)
2.4.2 Europe CRISPR And CRISPR-Associated (Cas) Genes Estimates and Projections (2015-2026)
2.4.3 China CRISPR And CRISPR-Associated (Cas) Genes Estimates and Projections (2015-2026)
2.4.4 Japan CRISPR And CRISPR-Associated (Cas) Genes Estimates and Projections (2015-2026)
2.4.5 Southeast Asia CRISPR And CRISPR-Associated (Cas) Genes Estimates and Projections (2015-2026)
2.4.6 India CRISPR And CRISPR-Associated (Cas) Genes Estimates and Projections (2015-2026)
3 Global CRISPR And CRISPR-Associated (Cas) Genes Competition Landscape by Players
3.1 Global Top CRISPR And CRISPR-Associated (Cas) Genes Players by Sales (2015-2020)
3.2 Global Top CRISPR And CRISPR-Associated (Cas) Genes Players by Revenue (2015-2020)
3.3 Global CRISPR And CRISPR-Associated (Cas) Genes Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CRISPR And CRISPR-Associated (Cas) Genes as of 2019)
3.4 Global CRISPR And CRISPR-Associated (Cas) Genes Average Price by Company (2015-2020)
3.5 Manufacturers CRISPR And CRISPR-Associated (Cas) Genes Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key CRISPR And CRISPR-Associated (Cas) Genes Players (Opinion Leaders)
4 Global CRISPR And CRISPR-Associated (Cas) Genes Market Size by Type
4.1 Global CRISPR And CRISPR-Associated (Cas) Genes Historic Market Review by Type (2015-2020)
4.1.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Type (2015-2020)
4.1.2 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue Market Share by Type (2015-2020)
4.1.3 Global CRISPR And CRISPR-Associated (Cas) Genes Price by Type (2014-2020)
4.2 Global CRISPR And CRISPR-Associated (Cas) Genes Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales Forecast by Type (2021-2026)
4.2.2 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue Forecast by Type (2021-2026)
4.2.3 Global CRISPR And CRISPR-Associated (Cas) Genes Price Forecast by Type (2021-2026)
5 Global CRISPR And CRISPR-Associated (Cas) Genes Market Size by Application
5.1 Global CRISPR And CRISPR-Associated (Cas) Genes Historic Market Review by Application (2015-2020)
5.1.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Application (2015-2020)
5.1.2 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue Market Share by Application (2015-2020)
5.1.3 Global CRISPR And CRISPR-Associated (Cas) Genes Price by Application (2015-2020)
5.2 Global CRISPR And CRISPR-Associated (Cas) Genes Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales Forecast by Application (2021-2026)
5.2.2 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue Forecast by Application (2021-2026)
5.2.3 Global CRISPR And CRISPR-Associated (Cas) Genes Price Forecast by Application (2021-2026)
3 North America CRISPR And CRISPR-Associated (Cas) Genes Market Facts & Figures
3.2 North America CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Company (2015-2020)
3.3 North America CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Type (2015-2020)
3.4 North America CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Application (2015-2020)
4 Europe CRISPR And CRISPR-Associated (Cas) Genes Market Facts & Figures
4.2 Europe CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Company (2015-2020)
4.3 Europe CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Type (2015-2020)
4.4 Europe CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Application (2015-2020)
5 China CRISPR And CRISPR-Associated (Cas) Genes Market Facts & Figures
5.2 China CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Company (2015-2020)
5.3 China CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Type (2015-2020)
5.4 China CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Application (2015-2020)
6 Japan CRISPR And CRISPR-Associated (Cas) Genes Market Facts & Figures
6.2 Japan CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Company (2015-2020)
6.3 Japan CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Type (2015-2020)
6.4 Japan CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Application (2015-2020)
7 Southeast Asia CRISPR And CRISPR-Associated (Cas) Genes Market Facts & Figures
7.2 Southeast Asia CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Company (2015-2020)
7.3 Southeast Asia CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Type (2015-2020)
7.4 Southeast Asia CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Application (2015-2020)
8 India CRISPR And CRISPR-Associated (Cas) Genes Market Facts & Figures
8.2 India CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Company (2015-2020)
8.3 India CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Type (2015-2020)
8.4 India CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in CRISPR And CRISPR-Associated (Cas) Genes Business
12.1 Caribou Biosciences
12.1.1 Caribou Biosciences CRISPR And CRISPR-Associated (Cas) Genes Corporation Information
12.1.2 Caribou Biosciences CRISPR And CRISPR-Associated (Cas) Genes Business Overview and Total Revenue
12.1.3 Caribou Biosciences CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Caribou Biosciences CRISPR And CRISPR-Associated (Cas) Genes Products Offered
12.1.5 Caribou Biosciences Recent Development
12.2 Addgene
12.2.1 Addgene CRISPR And CRISPR-Associated (Cas) Genes Corporation Information
12.2.2 Addgene CRISPR And CRISPR-Associated (Cas) Genes Business Overview and Total Revenue
12.2.3 Addgene CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Addgene CRISPR And CRISPR-Associated (Cas) Genes Products Offered
12.2.5 Addgene Recent Development
12.3 CRISPR THERAPEUTICS
12.3.1 CRISPR THERAPEUTICS CRISPR And CRISPR-Associated (Cas) Genes Corporation Information
12.3.2 CRISPR THERAPEUTICS CRISPR And CRISPR-Associated (Cas) Genes Business Overview and Total Revenue
12.3.3 CRISPR THERAPEUTICS CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Gross Margin (2015-2020)
12.3.4 CRISPR THERAPEUTICS CRISPR And CRISPR-Associated (Cas) Genes Products Offered
12.3.5 CRISPR THERAPEUTICS Recent Development
12.4 Merck KGaA
12.4.1 Merck KGaA CRISPR And CRISPR-Associated (Cas) Genes Corporation Information
12.4.2 Merck KGaA CRISPR And CRISPR-Associated (Cas) Genes Business Overview and Total Revenue
12.4.3 Merck KGaA CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Merck KGaA CRISPR And CRISPR-Associated (Cas) Genes Products Offered
12.4.5 Merck KGaA Recent Development
12.5 Mirus Bio LLC
12.5.1 Mirus Bio LLC CRISPR And CRISPR-Associated (Cas) Genes Corporation Information
12.5.2 Mirus Bio LLC CRISPR And CRISPR-Associated (Cas) Genes Business Overview and Total Revenue
12.5.3 Mirus Bio LLC CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Mirus Bio LLC CRISPR And CRISPR-Associated (Cas) Genes Products Offered
12.5.5 Mirus Bio LLC Recent Development
12.6 Editas Medicine
12.6.1 Editas Medicine CRISPR And CRISPR-Associated (Cas) Genes Corporation Information
12.6.2 Editas Medicine CRISPR And CRISPR-Associated (Cas) Genes Business Overview and Total Revenue
12.6.3 Editas Medicine CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Editas Medicine CRISPR And CRISPR-Associated (Cas) Genes Products Offered
12.6.5 Editas Medicine Recent Development
12.7 Takara Bio USA
12.7.1 Takara Bio USA CRISPR And CRISPR-Associated (Cas) Genes Corporation Information
12.7.2 Takara Bio USA CRISPR And CRISPR-Associated (Cas) Genes Business Overview and Total Revenue
12.7.3 Takara Bio USA CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Takara Bio USA CRISPR And CRISPR-Associated (Cas) Genes Products Offered
12.7.5 Takara Bio USA Recent Development
12.8 Thermo Fisher Scientific
12.8.1 Thermo Fisher Scientific CRISPR And CRISPR-Associated (Cas) Genes Corporation Information
12.8.2 Thermo Fisher Scientific CRISPR And CRISPR-Associated (Cas) Genes Business Overview and Total Revenue
12.8.3 Thermo Fisher Scientific CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Thermo Fisher Scientific CRISPR And CRISPR-Associated (Cas) Genes Products Offered
12.8.5 Thermo Fisher Scientific Recent Development
12.9 Horizon Discovery Group
12.9.1 Horizon Discovery Group CRISPR And CRISPR-Associated (Cas) Genes Corporation Information
12.9.2 Horizon Discovery Group CRISPR And CRISPR-Associated (Cas) Genes Business Overview and Total Revenue
12.9.3 Horizon Discovery Group CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Horizon Discovery Group CRISPR And CRISPR-Associated (Cas) Genes Products Offered
12.9.5 Horizon Discovery Group Recent Development
12.10 Intellia Therapeutics
12.10.1 Intellia Therapeutics CRISPR And CRISPR-Associated (Cas) Genes Corporation Information
12.10.2 Intellia Therapeutics CRISPR And CRISPR-Associated (Cas) Genes Business Overview and Total Revenue
12.10.3 Intellia Therapeutics CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Intellia Therapeutics CRISPR And CRISPR-Associated (Cas) Genes Products Offered
12.10.5 Intellia Therapeutics Recent Development
12.11 GE Healthcare Dharmacon
12.11.1 GE Healthcare Dharmacon CRISPR And CRISPR-Associated (Cas) Genes Corporation Information
12.11.2 GE Healthcare Dharmacon CRISPR And CRISPR-Associated (Cas) Genes Business Overview and Total Revenue
12.11.3 GE Healthcare Dharmacon CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Gross Margin (2015-2020)
12.11.4 GE Healthcare Dharmacon CRISPR And CRISPR-Associated (Cas) Genes Products Offered
12.11.5 GE Healthcare Dharmacon Recent Development
13 CRISPR And CRISPR-Associated (Cas) Genes Manufacturing Cost Analysis
13.1 CRISPR And CRISPR-Associated (Cas) Genes Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of CRISPR And CRISPR-Associated (Cas) Genes
13.4 CRISPR And CRISPR-Associated (Cas) Genes Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 CRISPR And CRISPR-Associated (Cas) Genes Distributors List
14.3 CRISPR And CRISPR-Associated (Cas) Genes Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four CRISPR And CRISPR-Associated (Cas) Genes Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for CRISPR And CRISPR-Associated (Cas) Genes Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for CRISPR And CRISPR-Associated (Cas) Genes Players to Combat Covid-19 Impact
Table 8. Global Market CRISPR And CRISPR-Associated (Cas) Genes Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units) by Region (2015-2020)
Table 10. Global CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Region (2015-2020)
Table 11. Global CRISPR And CRISPR-Associated (Cas) Genes Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global CRISPR And CRISPR-Associated (Cas) Genes Revenue Share by Region (2015-2020)
Table 13. Global CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share Forecast by Region (2021-2026)
Table 15. Global CRISPR And CRISPR-Associated (Cas) Genes Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global CRISPR And CRISPR-Associated (Cas) Genes Revenue Share Forecast by Region (2021-2026)
Table 17. Global CRISPR And CRISPR-Associated (Cas) Genes (K Units) of Key Companies (2015-2020)
Table 18. Global CRISPR And CRISPR-Associated (Cas) Genes Sales Share by Company (2015-2020)
Table 19. Global CRISPR And CRISPR-Associated (Cas) Genes Revenue (US$ Million) by Company (2015-2020)
Table 20. Global CRISPR And CRISPR-Associated (Cas) Genes Revenue Share by Company (2015-2020)
Table 21. Global CRISPR And CRISPR-Associated (Cas) Genes by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CRISPR And CRISPR-Associated (Cas) Genes as of 2019)
Table 22. Global CRISPR And CRISPR-Associated (Cas) Genes Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers CRISPR And CRISPR-Associated (Cas) Genes Manufacturing Sites and Area Served
Table 24. Manufacturers CRISPR And CRISPR-Associated (Cas) Genes Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key CRISPR And CRISPR-Associated (Cas) Genes Players
Table 27. Global CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units) by Type (2015-2020)
Table 28. Global CRISPR And CRISPR-Associated (Cas) Genes Sales Share by Type (2015-2020)
Table 29. Global CRISPR And CRISPR-Associated (Cas) Genes Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global CRISPR And CRISPR-Associated (Cas) Genes Price (K Units) by Type (2015-2020)
Table 31. Global CRISPR And CRISPR-Associated (Cas) Genes Sales Share by Type (2021-2026)
Table 32. Global CRISPR And CRISPR-Associated (Cas) Genes Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global CRISPR And CRISPR-Associated (Cas) Genes Revenue Share by Type (2021-2026)
Table 34. Global CRISPR And CRISPR-Associated (Cas) Genes Price (K Units) by Type (2021-2026)
Table 35. Global CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units) by Application (2015-2020)
Table 36. Global CRISPR And CRISPR-Associated (Cas) Genes Sales Share by Application (2015-2020)
Table 37. Global CRISPR And CRISPR-Associated (Cas) Genes Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global CRISPR And CRISPR-Associated (Cas) Genes Price (K Units) by Application (2015-2020)
Table 39. Global CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units) by Application (2021-2026)
Table 40. Global CRISPR And CRISPR-Associated (Cas) Genes Sales Share by Application (2021-2026)
Table 41. Global CRISPR And CRISPR-Associated (Cas) Genes Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global CRISPR And CRISPR-Associated (Cas) Genes Revenue Share by Application (2021-2026)
Table 43. Global CRISPR And CRISPR-Associated (Cas) Genes Price (K Units) by Application (2021-2026)
Table 44. United States CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units) by Company (2015-2020)
Table 45. United States CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Company (2015-2020)
Table 46. United States CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units) by Type (2015-2020)
Table 47. United States CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Type (2015-2020)
Table 48. United States CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units) by Application (2015-2020)
Table 49. United States CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Application (2015-2020)
Table 50. Europe CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units) by Company (2015-2020)
Table 51. Europe CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Company (2015-2020)
Table 52. Europe CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units) by Type (2015-2020)
Table 53. Europe CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Type (2015-2020)
Table 54. Europe CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units) by Application (2015-2020)
Table 55. Europe CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Type (2015-2020)
Table 56. China CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units) by Company (2015-2020)
Table 57. China CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Company (2015-2020)
Table 58. China CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units) by Type (2015-2020)
Table 59. China CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Type (2015-2020)
Table 60. China CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units) by Application (2015-2020)
Table 61. China CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Application (2015-2020)
Table 62. Japan CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units) by Company (2015-2020)
Table 63. Japan CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Company (2015-2020)
Table 64. Japan CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units) by Type (2015-2020)
Table 65. Japan CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Type (2015-2020)
Table 66. Japan CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units) by Application (2015-2020)
Table 67. Japan CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Application (2015-2020)
Table 74. India CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units) by Company (2015-2020)
Table 75. India CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Company (2015-2020)
Table 76. India CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units) by Type (2015-2020)
Table 77. India CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Type (2015-2020)
Table 78. India CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units) by Application (2015-2020)
Table 79. India CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Application (2015-2020)
Table 80. Caribou Biosciences Corporation Information
Table 81. Caribou Biosciences Description and Business Overview
Table 82. Caribou Biosciences CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Caribou Biosciences CRISPR And CRISPR-Associated (Cas) Genes Product
Table 84. Caribou Biosciences Recent Development
Table 85. Addgene Corporation Information
Table 86. Addgene Description and Business Overview
Table 87. Addgene CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Addgene CRISPR And CRISPR-Associated (Cas) Genes Product
Table 89. Addgene Recent Development
Table 90. CRISPR THERAPEUTICS Corporation Information
Table 91. CRISPR THERAPEUTICS Description and Business Overview
Table 92. CRISPR THERAPEUTICS CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. CRISPR THERAPEUTICS CRISPR And CRISPR-Associated (Cas) Genes Product
Table 94. CRISPR THERAPEUTICS Recent Development
Table 95. Merck KGaA Corporation Information
Table 96. Merck KGaA Description and Business Overview
Table 97. Merck KGaA CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Merck KGaA CRISPR And CRISPR-Associated (Cas) Genes Product
Table 99. Merck KGaA Recent Development
Table 100. Mirus Bio LLC Corporation Information
Table 101. Mirus Bio LLC Description and Business Overview
Table 102. Mirus Bio LLC CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Mirus Bio LLC CRISPR And CRISPR-Associated (Cas) Genes Product
Table 104. Mirus Bio LLC Recent Development
Table 105. Editas Medicine Corporation Information
Table 106. Editas Medicine Description and Business Overview
Table 107. Editas Medicine CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Editas Medicine CRISPR And CRISPR-Associated (Cas) Genes Product
Table 109. Editas Medicine Recent Development
Table 110. Takara Bio USA Corporation Information
Table 111. Takara Bio USA Description and Business Overview
Table 112. Takara Bio USA CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Takara Bio USA CRISPR And CRISPR-Associated (Cas) Genes Product
Table 114. Takara Bio USA Recent Development
Table 115. Thermo Fisher Scientific Corporation Information
Table 116. Thermo Fisher Scientific CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Thermo Fisher Scientific Description and Business Overview
Table 118. Thermo Fisher Scientific CRISPR And CRISPR-Associated (Cas) Genes Product
Table 119. Thermo Fisher Scientific Recent Development
Table 120. Horizon Discovery Group Corporation Information
Table 121. Horizon Discovery Group CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Horizon Discovery Group Description and Business Overview
Table 123. Horizon Discovery Group CRISPR And CRISPR-Associated (Cas) Genes Product
Table 124. Horizon Discovery Group Recent Development
Table 125. Intellia Therapeutics Corporation Information
Table 126. Intellia Therapeutics Description and Business Overview
Table 127. Intellia Therapeutics CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Intellia Therapeutics CRISPR And CRISPR-Associated (Cas) Genes Product
Table 129. Intellia Therapeutics Recent Development
Table . GE Healthcare Dharmacon Corporation Information
Table . GE Healthcare Dharmacon Description and Business Overview
Table . GE Healthcare Dharmacon CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . GE Healthcare Dharmacon CRISPR And CRISPR-Associated (Cas) Genes Product
Table . GE Healthcare Dharmacon Recent Development
Table 135. Production Base and Market Concentration Rate of Raw Material
Table 136. Key Suppliers of Raw Materials
Table 137. CRISPR And CRISPR-Associated (Cas) Genes Distributors List
Table 138. CRISPR And CRISPR-Associated (Cas) Genes Customers List
Table 139. Market Key Trends
Table 140. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 141. Key Challenges
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. CRISPR And CRISPR-Associated (Cas) Genes Product Picture
Figure 2. Global CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global CRISPR And CRISPR-Associated (Cas) Genes Market Share by Application in 2020 & 2026
Figure 6. Biotechnology Companies Examples
Figure 7. Pharmaceutical Companies Examples
Figure 8. Academic Institutes Examples
Figure 9. Research and Development Institutes Examples
Figure 10. Global CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units) Growth Rate (2015-2026)
Figure 11. Global CRISPR And CRISPR-Associated (Cas) Genes Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global CRISPR And CRISPR-Associated (Cas) Genes Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 13. Global CRISPR And CRISPR-Associated (Cas) Genes Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global CRISPR And CRISPR-Associated (Cas) Genes Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States CRISPR And CRISPR-Associated (Cas) Genes Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units) Growth Rate (2015-2026)
Figure 17. Europe CRISPR And CRISPR-Associated (Cas) Genes Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe CRISPR And CRISPR-Associated (Cas) Genes Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China CRISPR And CRISPR-Associated (Cas) Genes Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China CRISPR And CRISPR-Associated (Cas) Genes Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan CRISPR And CRISPR-Associated (Cas) Genes Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan CRISPR And CRISPR-Associated (Cas) Genes Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia CRISPR And CRISPR-Associated (Cas) Genes Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia CRISPR And CRISPR-Associated (Cas) Genes Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India CRISPR And CRISPR-Associated (Cas) Genes Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India CRISPR And CRISPR-Associated (Cas) Genes Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest CRISPR And CRISPR-Associated (Cas) Genes Players Market Share by Revenue in CRISPR And CRISPR-Associated (Cas) Genes 2015 & 2019
Figure 28. CRISPR And CRISPR-Associated (Cas) Genes Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global CRISPR And CRISPR-Associated (Cas) Genes Revenue Share by Type (2015-2020)
Figure 30. Global CRISPR And CRISPR-Associated (Cas) Genes Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global CRISPR And CRISPR-Associated (Cas) Genes Revenue Share by Application (2015-2020)
Figure 32. Global CRISPR And CRISPR-Associated (Cas) Genes Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Type in 2019
Figure 34. United States CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Type in 2019
Figure 35. Europe CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Company in 2019
Figure 36. Europe CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Type in 2019
Figure 37. Europe CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Application in 2019
Figure 38. China CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Company in 2019
Figure 39. China CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Type in 2019
Figure 40. China CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Application in 2019
Figure 41. Japan CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Company in 2019
Figure 42. Japan CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Type in 2019
Figure 43. Japan CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Application in 2019
Figure 44. Southeast Asia CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Company in 2019
Figure 45. Southeast Asia CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Type in 2019
Figure 46. Southeast Asia CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Application in 2019
Figure 47. India CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Company in 2019
Figure 48. India CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Type in 2019
Figure 49. India CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Application in 2019
Figure 50. Caribou Biosciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Addgene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. CRISPR THERAPEUTICS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Merck KGaA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Mirus Bio LLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Editas Medicine Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Takara Bio USA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Thermo Fisher Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Horizon Discovery Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Intellia Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. GE Healthcare Dharmacon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Key Raw Materials Price Trend
Figure 62. Manufacturing Cost Structure of CRISPR And CRISPR-Associated (Cas) Genes
Figure 63. Manufacturing Process Analysis of CRISPR And CRISPR-Associated (Cas) Genes
Figure 64. CRISPR And CRISPR-Associated (Cas) Genes Industrial Chain Analysis
Figure 65. Channels of Distribution
Figure 66. Distributors Profiles
Figure 67. Porter's Five Forces Analysis
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
ゲノムエンジニアリングの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Genome Engineering market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 8.9% in the forecast period of 2020 to 2025 and will expected to reach USD 4759.2 million by 2025, from USD 3386.9 million in 2019. The Genome Engineerin…- オリゴヌクレオチドプールライブラリの世界市場レポート2020 Oligo pools, which are high diversity collections of oligonucleotides, are utilized to generate CRISPR guide RNA (sgRNA) libraries for cloning into expression vectors. Accuracy and uniformity of oligo synthesis are critical to ensure specificity of targeting and oligo representation. This report stu…
- ヒト胚性幹細胞（HESC）の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Human Embryonic Stem Cells (HESC) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Human Embry…
- 遺伝子組み換え食品の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Genetically Modified Food market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.2% in the forecast period of 2020 to 2025 and will expected to reach USD 134130 million by 2025, from USD 105290 million in 2019. The Geneticall…
- 動物幹細胞療法の世界市場レポート2020 Animal stem cell therapy is a usage of animal’s stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process involves three …